nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—Cardiac failure congestive—Dexamethasone—psoriatic arthritis	0.0067	0.0067	CcSEcCtD
Pindolol—Cardiac failure congestive—Betamethasone—psoriatic arthritis	0.0067	0.0067	CcSEcCtD
Pindolol—Nausea—Auranofin—psoriatic arthritis	0.00667	0.00667	CcSEcCtD
Pindolol—Visual disturbance—Betamethasone—psoriatic arthritis	0.00642	0.00642	CcSEcCtD
Pindolol—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00642	0.00642	CcSEcCtD
Pindolol—Cardiac failure—Dexamethasone—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Pindolol—Cardiac failure—Betamethasone—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Pindolol—Lethargy—Betamethasone—psoriatic arthritis	0.00621	0.00621	CcSEcCtD
Pindolol—Lethargy—Dexamethasone—psoriatic arthritis	0.00621	0.00621	CcSEcCtD
Pindolol—Cardiac failure congestive—Prednisone—psoriatic arthritis	0.00584	0.00584	CcSEcCtD
Pindolol—Weight increased—Prednisolone—psoriatic arthritis	0.00573	0.00573	CcSEcCtD
Pindolol—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00568	0.00568	CcSEcCtD
Pindolol—Conjunctivitis—Prednisolone—psoriatic arthritis	0.00546	0.00546	CcSEcCtD
Pindolol—Cardiac failure—Prednisone—psoriatic arthritis	0.00543	0.00543	CcSEcCtD
Pindolol—Lethargy—Prednisone—psoriatic arthritis	0.0054	0.0054	CcSEcCtD
Pindolol—Weight increased—Triamcinolone—psoriatic arthritis	0.00527	0.00527	CcSEcCtD
Pindolol—Weight increased—Methylprednisolone—psoriatic arthritis	0.00526	0.00526	CcSEcCtD
Pindolol—Bradycardia—Prednisolone—psoriatic arthritis	0.00513	0.00513	CcSEcCtD
Pindolol—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00502	0.00502	CcSEcCtD
Pindolol—Sweating—Methylprednisolone—psoriatic arthritis	0.00494	0.00494	CcSEcCtD
Pindolol—Visual impairment—Prednisolone—psoriatic arthritis	0.00486	0.00486	CcSEcCtD
Pindolol—Weight increased—Dexamethasone—psoriatic arthritis	0.00478	0.00478	CcSEcCtD
Pindolol—Weight increased—Betamethasone—psoriatic arthritis	0.00478	0.00478	CcSEcCtD
Pindolol—Bradycardia—Triamcinolone—psoriatic arthritis	0.00472	0.00472	CcSEcCtD
Pindolol—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00471	0.00471	CcSEcCtD
Pindolol—Visual disturbance—Methotrexate—psoriatic arthritis	0.00467	0.00467	CcSEcCtD
Pindolol—Hallucination—Methylprednisolone—psoriatic arthritis	0.0046	0.0046	CcSEcCtD
Pindolol—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00455	0.00455	CcSEcCtD
Pindolol—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00455	0.00455	CcSEcCtD
Pindolol—Lethargy—Methotrexate—psoriatic arthritis	0.00452	0.00452	CcSEcCtD
Pindolol—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00446	0.00446	CcSEcCtD
Pindolol—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00429	0.00429	CcSEcCtD
Pindolol—Bradycardia—Dexamethasone—psoriatic arthritis	0.00428	0.00428	CcSEcCtD
Pindolol—Bradycardia—Betamethasone—psoriatic arthritis	0.00428	0.00428	CcSEcCtD
Pindolol—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00422	0.00422	CcSEcCtD
Pindolol—Angiopathy—Methylprednisolone—psoriatic arthritis	0.0042	0.0042	CcSEcCtD
Pindolol—Hallucination—Betamethasone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Pindolol—Hallucination—Dexamethasone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Pindolol—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00417	0.00417	CcSEcCtD
Pindolol—Weight increased—Prednisone—psoriatic arthritis	0.00417	0.00417	CcSEcCtD
Pindolol—Depression—Prednisone—psoriatic arthritis	0.00407	0.00407	CcSEcCtD
Pindolol—Visual impairment—Dexamethasone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Pindolol—Visual impairment—Betamethasone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Pindolol—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Pindolol—Vertigo—Prednisolone—psoriatic arthritis	0.00394	0.00394	CcSEcCtD
Pindolol—Syncope—Prednisolone—psoriatic arthritis	0.00394	0.00394	CcSEcCtD
Pindolol—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Pindolol—Angiopathy—Betamethasone—psoriatic arthritis	0.00382	0.00382	CcSEcCtD
Pindolol—Angiopathy—Dexamethasone—psoriatic arthritis	0.00382	0.00382	CcSEcCtD
Pindolol—Bradycardia—Prednisone—psoriatic arthritis	0.00373	0.00373	CcSEcCtD
Pindolol—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Pindolol—Hallucination—Prednisone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Pindolol—Vertigo—Triamcinolone—psoriatic arthritis	0.00363	0.00363	CcSEcCtD
Pindolol—Syncope—Triamcinolone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Pindolol—Vertigo—Methylprednisolone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Pindolol—Syncope—Methylprednisolone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Pindolol—Oedema—Prednisolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Pindolol—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00355	0.00355	CcSEcCtD
Pindolol—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Pindolol—Shock—Prednisolone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Pindolol—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Pindolol—Tachycardia—Prednisolone—psoriatic arthritis	0.0035	0.0035	CcSEcCtD
Pindolol—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Pindolol—Myalgia—Triamcinolone—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Pindolol—Myalgia—Methylprednisolone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Pindolol—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Pindolol—Anxiety—Methylprednisolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Pindolol—Drowsiness—Methotrexate—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Pindolol—Depression—Methotrexate—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Pindolol—Dry mouth—Triamcinolone—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Pindolol—Angiopathy—Prednisone—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Pindolol—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Pindolol—Confusional state—Methylprednisolone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Pindolol—Oedema—Triamcinolone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Pindolol—Vertigo—Dexamethasone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Pindolol—Vertigo—Betamethasone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Pindolol—Syncope—Dexamethasone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Pindolol—Syncope—Betamethasone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Pindolol—Sweating—Methotrexate—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Pindolol—Shock—Triamcinolone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Pindolol—Insomnia—Prednisolone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Pindolol—Shock—Methylprednisolone—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Pindolol—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Pindolol—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Pindolol—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Pindolol—Paraesthesia—Prednisolone—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Pindolol—Tachycardia—Triamcinolone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Pindolol—Mental disorder—Prednisone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Pindolol—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Pindolol—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Pindolol—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Pindolol—Myalgia—Dexamethasone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Pindolol—Myalgia—Betamethasone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Pindolol—Anxiety—Dexamethasone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Pindolol—Anxiety—Betamethasone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Pindolol—Hypotension—Methylprednisolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Pindolol—Pain—Prednisolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Pindolol—Oedema—Betamethasone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Pindolol—Oedema—Dexamethasone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Pindolol—Insomnia—Triamcinolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Pindolol—Insomnia—Methylprednisolone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Pindolol—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Pindolol—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Pindolol—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Pindolol—Visual impairment—Methotrexate—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Pindolol—Shock—Betamethasone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Pindolol—Shock—Dexamethasone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Pindolol—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Pindolol—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00293	0.00293	CcSEcCtD
Pindolol—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00293	0.00293	CcSEcCtD
Pindolol—Tachycardia—Dexamethasone—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Pindolol—Tachycardia—Betamethasone—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Pindolol—Dyspepsia—Triamcinolone—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Pindolol—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Pindolol—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Pindolol—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Pindolol—Vertigo—Prednisone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Pindolol—Syncope—Prednisone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Pindolol—Tinnitus—Methotrexate—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Pindolol—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Pindolol—Fatigue—Triamcinolone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Pindolol—Fatigue—Methylprednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Pindolol—Pain—Triamcinolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Pindolol—Loss of consciousness—Prednisone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Pindolol—Hypotension—Dexamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Pindolol—Hypotension—Betamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Pindolol—Angiopathy—Methotrexate—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Pindolol—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Pindolol—Arthralgia—Prednisone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Pindolol—Myalgia—Prednisone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Pindolol—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Pindolol—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Pindolol—Anxiety—Prednisone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Pindolol—Insomnia—Dexamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Pindolol—Insomnia—Betamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Pindolol—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Pindolol—Paraesthesia—Betamethasone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Pindolol—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Pindolol—Mental disorder—Methotrexate—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Pindolol—Dyspepsia—Betamethasone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Pindolol—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Pindolol—Oedema—Prednisone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Pindolol—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Pindolol—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Pindolol—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Pindolol—Fatigue—Dexamethasone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Pindolol—Fatigue—Betamethasone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Pindolol—Shock—Prednisone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Pindolol—Pain—Dexamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Pindolol—Pain—Betamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Pindolol—Nervous system disorder—Prednisone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Pindolol—Tachycardia—Prednisone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Pindolol—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Pindolol—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Pindolol—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Pindolol—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Pindolol—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Pindolol—Vertigo—Methotrexate—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Pindolol—Dizziness—Prednisolone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Pindolol—Asthenia—Triamcinolone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Pindolol—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Pindolol—Abdominal pain—Betamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Pindolol—Asthenia—Methylprednisolone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Pindolol—Insomnia—Prednisone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Pindolol—Paraesthesia—Prednisone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Pindolol—Pruritus—Triamcinolone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Pindolol—Pruritus—Methylprednisolone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Pindolol—Dyspepsia—Prednisone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Pindolol—Arthralgia—Methotrexate—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Pindolol—Chest pain—Methotrexate—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Pindolol—Myalgia—Methotrexate—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Pindolol—Rash—Prednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Pindolol—Dermatitis—Prednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Pindolol—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Pindolol—Fatigue—Prednisone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Pindolol—Headache—Prednisolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Pindolol—Constipation—Prednisone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Pindolol—Confusional state—Methotrexate—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Pindolol—Dizziness—Triamcinolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Pindolol—Dizziness—Methylprednisolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Pindolol—Feeling abnormal—Prednisone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Pindolol—Asthenia—Dexamethasone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Pindolol—Asthenia—Betamethasone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Pindolol—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Pindolol—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Pindolol—Nausea—Prednisolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Pindolol—Pruritus—Dexamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Pindolol—Pruritus—Betamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Pindolol—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Pindolol—Vomiting—Triamcinolone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Pindolol—Vomiting—Methylprednisolone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Pindolol—Rash—Triamcinolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Pindolol—Dermatitis—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Pindolol—Rash—Methylprednisolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Pindolol—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Pindolol—Headache—Triamcinolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Pindolol—Headache—Methylprednisolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Pindolol—Abdominal pain—Prednisone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Pindolol—Diarrhoea—Betamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Pindolol—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Pindolol—Hypotension—Methotrexate—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Pindolol—Dizziness—Betamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Pindolol—Dizziness—Dexamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Pindolol—Insomnia—Methotrexate—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Pindolol—Nausea—Triamcinolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Pindolol—Paraesthesia—Methotrexate—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Pindolol—Nausea—Methylprednisolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Pindolol—Dyspnoea—Methotrexate—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Pindolol—Somnolence—Methotrexate—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Pindolol—Dyspepsia—Methotrexate—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Pindolol—Vomiting—Betamethasone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Pindolol—Vomiting—Dexamethasone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Pindolol—Rash—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Pindolol—Rash—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Pindolol—Dermatitis—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Pindolol—Dermatitis—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Pindolol—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Pindolol—Fatigue—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Pindolol—Headache—Dexamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pindolol—Headache—Betamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pindolol—Asthenia—Prednisone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pindolol—Pain—Methotrexate—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Pindolol—Pruritus—Prednisone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Pindolol—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Pindolol—Diarrhoea—Prednisone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Pindolol—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Pindolol—Nausea—Betamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Pindolol—Nausea—Dexamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Pindolol—Dizziness—Prednisone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Pindolol—Abdominal pain—Methotrexate—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Pindolol—Vomiting—Prednisone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Pindolol—Rash—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Pindolol—Dermatitis—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Pindolol—Headache—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Pindolol—Asthenia—Methotrexate—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Pindolol—Nausea—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Pindolol—Pruritus—Methotrexate—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Pindolol—Diarrhoea—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Pindolol—Dizziness—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Pindolol—Vomiting—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Pindolol—Rash—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Pindolol—Dermatitis—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Pindolol—Headache—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Pindolol—Nausea—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
